The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2016 – 2018 Ranges: (44.16 – 69.21) (58.66 – 88.98) (64.38 – 101.55)
1-Month Range: 83.10 – 96.61
Weekly Chart
Daily Chart
5 Day Chart
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 100.68 | |
| 13-Week High | 96.61 | |
| 52-Week High | 96.61 | |
| 1-Month High | 96.61 | |
| Last | 95.36 | Last |
| 14 Day RSI at 70% | 95.19 | |
| 91.45 | 38.2% Retracement From 4 Week High | |
| 90.39 | 14 Day RSI at 50% | |
| 89.85 | 50% Retracement From 4 Week High/Low | |
| 88.26 | 38.2% Retracement From 4 Week Low | |
| 87.58 | 38.2% Retracement From 13 Week High | |
| 84.79 | 50% Retracement From 13 Week High/Low | |
| 84.30 | 38.2% Retracement From 52 Week High | |
| 1-Month Low | 83.10 | |
| 82.00 | 38.2% Retracement From 13 Week Low | |
| 80.49 | 50% Retracement From 52 Week High/Low | |
| 14 Day RSI at 30% | 79.19 | |
| 76.69 | 38.2% Retracement From 52 Week Low | |
| 13-Week Low | 72.97 | |
| 14 Day RSI at 20% | 65.19 | |
| 52-Week Low | 64.38 |
